ProCE Banner Series

Meeting the Challenge: Transforming Patient Care in sHTG and FCS With Novel RNA-Based Therapies

Join leading experts at this ACC satellite symposium to explore the latest advancements in RNA-based therapies for severe hypertriglyceridemia (sHTG) and familial chylomicronemia syndrome (FCS). Gain insights into emerging clinical data, patient selection, and the evolving treatment landscape to optimize care for these high-risk patients.

This event is not part of ACC.25, as planned by its Program Committee, and does not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Who Should Attend

This educational program is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with sHTG, including FCS.

All Events

Meeting the Challenge: Transforming Patient Care in sHTG and FCS With Novel RNA-Based Therapies

Upcoming Events

March

29

2025

6:30 PM - 8:30 PM Central Time (CT)

In-person

Hyatt Regency McCormick Place, 2233 S Martin Luther King Dr, Chicago, Illinois 60616

7:00 PM - 8:30 PM Central Time (CT)

Virtual

Topics

Dyslipidemia

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Dyslipidemia.

Target Audience
This educational program is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with sHTG, including FCS.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by a grant from Ionis Pharmaceuticals, Inc.